ScreenerHero

ACE Ascelia Pharma AB (publ)

STO · SE · Healthcare · Biotechnology · ascelia.com
0.8560SEK+22.29%Mkt Cap: 10.93M $P/E: —

Ascelia Pharma AB (publ), a biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden. It develops Orviglance, a novel non-gadolinium diagnostic drug, wh…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.47BUSDP/E 29.3
MRNA
Moderna, Inc.
$78.65BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.14BUSDP/E 18.3
ARGX
argenx SE
$51.48BUSDP/E 31.2
ARGX
argenx SE
$48.23BUSDP/E 31.4
UCB
UCB SA
$41.82BUSDP/E 17.8
RVMD
Revolution Medicines, Inc.
$40.32BUSD
ONC
BeOne Medicines AG
$39.83BUSDP/E 62.6
RPRX
Royalty Pharma plc
$32.48BUSDP/E 29.9
ALNY
Alnylam Pharmaceuticals, Inc.
$30.04BUSDP/E 37.9
ROIV
Roivant Sciences Ltd.
$24.71BUSD
BNTX
BioNTech SE
$23.13BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
GMAB
Genmab A/S
$22.17BUSDP/E 28.4
INSM
Insmed Incorporated
$21.94BUSD
GMAB
Genmab A/S
$21.10BUSDP/E 29.1
ASND
Ascendis Pharma A/S
$14.65BUSDP/E 17.1
EXEL
Exelixis, Inc.
$14.62BUSDP/E 18.6
JAZZ
Jazz Pharmaceuticals plc
$14.44BUSDP/E 15.2
SMMT
Summit Therapeutics Inc.
$13.70BUSD

Key Statistics

Company
Market Cap10.93M USD
Enterprise Value6.53M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-7.29M USD
Revenue/Share—
Last Price0.8560 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0010573113
Valuation
P/E (Trailing)—
P/E (Forward)-6.68
PEG—
EV/EBITDA-1.15
EV/Revenue—
P/S—
P/B1.18
EPS (TTM)-0.48
EPS (Forward)-0.12
52W Range
0.455013% of range3.550
52W High3.550 SEK
52W Low0.4550 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-76.66%
ROA-68.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.91M USD
CapEx (TTM)5.45K USD
FCF Margin—
FCF Yield-40.36%
Net Debt-3.59M USD
Net Debt/EBITDA0.63
Balance Sheet
Debt/Equity0.01
Current Ratio4.11
Quick Ratio4.01
Book Value/Sh0.68 SEK
Cash/Share0.29 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.950 SEK
Upside (mean)+127.8%
Target Range1.000 SEK – 3.700 SEK
1.000+127.8% to mean3.700
# Analysts3
Ownership
Shares Out.133.54M
Float124.71M
Insiders13.35%
Institutions21.70%
Technical
SMA 500.6185 (+38.4%)
SMA 2002.201 (-61.1%)
Beta0.77
S&P 52W Chg16.45%
Avg Vol (30d)964.59K
Avg Vol (10d)1.61M
Technical Indicators
RSI (14)64.9
MACD0.0374
MACD Signal0.0162
MACD Hist.+0.0212
BB Upper0.8655 SEK
BB Middle0.6828 SEK
BB Lower0.5001 SEK
BB Width53.51%
ATR (14)0.0883 SEK
Vol Ratio (20d)1.81x